Current Pharmaceutical Design
Title: Editorial [ Anti-Angiogenesis Agents Executive Editor: Cezary Marcinkiewicz ]
Volume: 12 Issue: 21
Author(s): Cezary Marcinkiewicz
Affiliation:
Export Options
About this article
Cite this article as:
Marcinkiewicz Cezary, Editorial [ Anti-Angiogenesis Agents Executive Editor: Cezary Marcinkiewicz ], Current Pharmaceutical Design 2006; 12 (21) . https://dx.doi.org/10.2174/138161206777698765
DOI https://dx.doi.org/10.2174/138161206777698765 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Mechanoinsensitive Nociceptors in Painful Diabetic Peripheral
Neuropathy
Current Diabetes Reviews New Recombinant Serotypes of AAV Vectors
Current Gene Therapy Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile
Current Drug Safety Targeting Molecular Imaging Approach for Detection of Infection and Inflammation by Diagnostic Nuclear Medicine Techniques
Current Medical Imaging The Ayurvedic Bhasma: The Ancient Science of Nanomedicine
Recent Patents on Nanomedicine Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
Current Stem Cell Research & Therapy Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Possible Molecular Mechanisms by which Vitamin D Prevents Inflammatory Bowel Disease and Colitis-associated Colorectal Cancer
Current Medicinal Chemistry Contemporary Treatment of Amyloid Heart Disease
Current Pharmaceutical Design Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
Current Drug Metabolism Anticipation in Lynch Syndrome: Where We Are Where We Go
Current Genomics E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets
Current Cancer Drug Targets Use of Lactobacilli and their Pheromone-Based Regulatory Mechanism in Gene Expression and Drug Delivery
Current Pharmaceutical Biotechnology Mouse Models of Autoimmune Uveitis
Current Pharmaceutical Design Curcumin in Combined Cancer Therapy
Current Pharmaceutical Design Immune Responses to Fungal Infections and Therapeutic Implications
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Cytotoxicity and Anti-Inflammatory Effects of Polyherbal Formulations, Joint Pain Spl and Rumalaya Forte on Lipopolysaccharide Induced Inflammation in IC-21 Macrophages
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Immunoglobulin Free Light Chains in Immune Responses
Current Immunology Reviews (Discontinued) Exploration of the Medicinal Peptide Space
Protein & Peptide Letters Covalently and Ionically Crosslinked Chitosan Nanogels for Drug Delivery
Current Pharmaceutical Design